Trial NCT01856101

View at ClinicalTrials.gov 
Org. Study IDs: UCL-ONCO2012-01
Secondary IDs: 2012-004123-20 CBEZ235ZBE01T

Last trial update was posted on 2019-04-10

MeSH Interventions

Dactolisib MTOR Inhibitors

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell

Other Conditions

Carcinoma Transitional Cell

Stopping Reasons

Novartis decided to stop the marketing of BEZ235

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID